Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

被引:2150
作者
Carmeliet, P [1 ]
Dor, Y
Herbert, JM
Fukumura, D
Brusselmans, K
Dewerchin, M
Neeman, M
Bono, F
Abramovitch, R
Maxwell, P
Koch, CJ
Ratcliffe, P
Moons, L
Jain, RK
Collen, D
Keshet, E
机构
[1] Catholic Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel
[3] Sanofi Rech, Haemobiol Res Dept, F-31036 Toulouse, France
[4] Harvard Univ, Sch Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[6] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
[7] John Radcliffe Hosp, Welcome Trust Ctr Human Genet, Inst Mol Med, Oxford OX3 7BN, England
[8] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
基金
英国惠康基金;
关键词
D O I
10.1038/28867
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As a result of deprivation of oxygen (hypoxia) and nutrients, the growth and viability of cells is reduced(1). Hypoxia-inducible factor (KIF)-1 alpha helps to restore oxygen homeostasis by inducing glycolysis, erythropoiesis and angiogenesis(2-4). Here we show that hypoxia and hypoglycaemia reduce proliferation and increase apoptosis in wild-type (HIF-1 alpha(+/+)) embryonic stem (ES) cells, but not in ES cells with inactivated HIF-1 alpha. genes (HIF-1 alpha(-/-)); however, a deficiency of HIF-1 alpha does not affect apoptosis induced by cytokines. We find that hypoxia/hypoglycaemia-regulated genes involved in controlling the cell cycle are either HIF-1 alpha-dependent (those encoding the proteins p53, p21, Bcl-2) or HLF-1 alpha-independent (p27, GADD153), suggesting that there are at least two different adaptive responses to being deprived of oxygen and nutrients, Loss of HIF-1 alpha. reduces hypoxia-induced expression of vascular endothelial growth factor, prevents formation of large vessels in ES-derived tumours, and impairs vascular function, resulting in hypoxic microenvironments within the tumour mass, However, growth of HIF-1 alpha. tumours was not retarded but was accelerated, owing to decreased hypoxia-induced apoptosis and increased stress-induced proliferation. As hypoxic stress contributes to many (patho)biological disorders(1,5), this new role for HIF-1 alpha in hypoxic control of cell growth and death may be of general pathophysiological importance.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 31 条
  • [1] Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
    Abramovitch, R
    Frenkiel, D
    Neeman, M
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1998, 39 (05) : 813 - 824
  • [2] Stabilization of wild-type p53 by hypoxia-inducible factor 1α
    An, WG
    Kanekal, M
    Simon, MC
    Maltepe, E
    Blagosklonny, MV
    Neckers, LM
    [J]. NATURE, 1998, 392 (6674) : 405 - 408
  • [3] Oxygen sensing and molecular adaptation to hypoxia
    Bunn, HF
    Poyton, RO
    [J]. PHYSIOLOGICAL REVIEWS, 1996, 76 (03) : 839 - 885
  • [4] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [5] GROWTH-FACTORS AS SURVIVAL FACTORS - REGULATION OF APOPTOSIS
    COLLINS, MKL
    PERKINS, GR
    RODRIGUEZTARDUCHY, G
    NIETO, MA
    LOPEZRIVAS, A
    [J]. BIOESSAYS, 1994, 16 (02) : 133 - 138
  • [6] Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO
  • [7] 2-D
  • [8] Ischemia-driven angiogenesis
    Dor, Y
    Keshet, E
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (08) : 289 - 294
  • [9] IDENTIFICATION OF HYPOXIA IN CELLS AND TISSUES OF EPIGASTRIC 9L RAT GLIOMA USING EF5 [2-(2-NITRO-1H-IMIDAZOL-1-YL)-N-(2,2,3,3,3-PENTAFLUOROPROPYL) ACETAMIDE]
    EVANS, SM
    JOINER, B
    JENKINS, WT
    LAUGHLIN, KM
    LORD, EM
    KOCH, CJ
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 875 - 882
  • [10] Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138